Current Studies

Ichor Research is conducting a study that evaluates whether an investigational drug can slow the Alzheimer's Disease process. ​Interested volunteers can find more information about this study here.

Of the millions of individuals living with Alzheimer’s Disease, about half are affected by agitation, which often accompanies Alzheimer’s Disease.  Though common, the symptoms of agitation can be challenging for patients and their caregivers.

Researchers are evaluating investigational treatments for agitation associated with Alzheimer’s Disease.  You can learn more here.

Nearly 1 in 5 adults in the U.S. has experienced depression. Adults who suffer from depression, despite trying existing medicines, may qualify for a new clinical trial.  Ichor Research is running a clinical study that tests an investigational drug to see if it can help with difficult-to-treat depression.  

Your experience with treatment-resistant depression matters—consider enrolling in our study to contribute to potential new answers.  You can learn more here.

Ichor Research and Hollister Incorporated are running a clinical study that tests ostomy samples. This study may help Hollister Incorporated to develop ostomy care products.  Qualifying participants will be compensated for their time.

​

Interested volunteers can find more information about this study here.

Pemvidutide is an investigational GLP-1 drug that is being evaluated by for its ability to help people cut back on drinking, and to treat liver damage caused by drinking.  Qualifying adults may be eligible to enroll in a clinical trial that will test Pemvidutide’s efficacy in reducing alcohol consumption and treating liver damage.  Participants will be compensated for their time.

​

Interested volunteers can find more information about this study here.

Your final act could change lives. Consider donating your brain to research and help fight Alzheimer’s disease.

​Learn more here.